MedPath
HSA Approval

ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSION

SIN15302P

ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSION

ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSION

July 24, 2017

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Therapeutic

Prescription Only

Formulation Information

INFUSION, SOLUTION CONCENTRATE

INTRAVENOUS

Medical Information

B05XA31

electrolytes in combination with other drugs

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

Fresenius Kabi Norge AS

Active Ingredients

Potassium Iodide

16.6 mcg/ml

Potassium Iodide

Chromic Chloride Hexahydrate

5.33 mcg/ml

Chromic chloride

Sodium Fluoride

210 mcg/ml

Sodium fluoride

Sodium Molybdate Dihydrate

4.85 mcg/ml

Sodium molybdate

Sodium Selenite Anhydrous

17.29 mcg/ml

Selenious acid

Copper Chloride Dihydrate

102.3 mcg/ml

Ferric Chloride Hexahydrate

540 mcg/ml

Ferric chloride

Manganese Chloride Tetrahydrate

19.79 mcg/ml

Manganese

Zinc Chloride

1050 mcg/ml

Zinc chloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSION - HSA Approval | MedPath